AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.03
-0.08 (-0.93%)
At close: May 13, 2025, 4:00 PM
8.95
-0.08 (-0.83%)
Pre-market: May 14, 2025, 4:12 AM EDT

Company Description

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States.

The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies.

The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.

AdaptHealth Corp.
AdaptHealth logo
Country United States
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 10,500
CEO Suzanne Foster

Contact Details

Address:
220 West Germantown Pike, Suite 250
Plymouth Meeting, Pennsylvania 19462
United States
Phone 610 424 4515
Website adapthealth.com

Stock Details

Ticker Symbol AHCO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001725255
CUSIP Number 00653Q102
ISIN Number US00653Q1022
Employer ID 82-3677704
SIC Code 8082

Key Executives

Name Position
Nalin Narayanam Chief Information Officer
Wendy Russalesi Chief Compliance Officer
Richard W. Rew II Chief Legal Officer, General Counsel and Secretary
Joel Mills Chief People Officer
Russell E. Schuster III Chief Commercial Officer
Philip Parks Chief Innovation and Strategy Officer
Michael Myint Chief Information Security Officer
Dan McFadden Chief Business Systems Officer

Latest SEC Filings

Date Type Title
May 12, 2025 SCHEDULE 13G/A Filing
May 6, 2025 10-Q Quarterly Report
May 6, 2025 8-K Current Report
May 2, 2025 SCHEDULE 13G/A Filing
May 2, 2025 SCHEDULE 13G Filing
Apr 30, 2025 ARS Filing
Apr 30, 2025 DEF 14A Other definitive proxy statements
Feb 25, 2025 10-K Annual Report
Feb 25, 2025 8-K Current Report
Feb 13, 2025 SCHEDULE 13G/A Filing